Opens in a new tab

40 Year Old Rx-pharma Manufacturing Business

Country
IndiaIndia
Listing ID
L#20210016
Target Price
$12,000,000
Revenue
$1,900,000
EBITDA
TBA

Description

This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).

The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.

Company produces Generic, Nutraceuticals and Herbal Medical Products.

Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.

Products

438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.

Overarching Competitive Advantage

High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.

Basic Details

Listing ID
L#20210016
Country
India
City
Bangalore
Industry
Manufacturing
Deal Status
Available
Established
1982
Reason for Selling
Retirement
Target Price
$12,000,000
Revenue
$1,900,000
EBITDA
TBA
Revenue Multiple
6.32x
EBITDA Multiple
TBD

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000